In English | En español
Questions About Cancer? 1-800-4-CANCER

Find News Releases

Search For:
Between these dates:

All News Releases

U of Pittsburgh researchers potentially find a better way to track emerging cell therapies using MRIs
NCI Cancer Center News
(Posted: 09/22/2014) - Researchers describe the first human tests of using a perfluorocarbon (PFC) tracer in combination with non-invasive magnetic resonance imaging (MRI) to track therapeutic immune cells injected into patients with colorectal cancer.

UPenn researchers find that in mouse study, exercise added to chemo shrinks tumors faster
NCI Cancer Center News
(Posted: 09/22/2014) - Adding exercise to a regimen of chemotherapy shrinks tumors more than chemotherapy alone, according to a study with mice.

Stanford researchers create evolved protein in mice that may stop cancer from spreading
NCI Cancer Center News
(Posted: 09/22/2014) - Stanford researchers have created a decoy protein designed to interrupt the signaling pathway that triggers the breakaway of cancerous cells; in other words the signal that initiates metastasis.

MD Anderson researchers find that cancer cells adapt energy needs to spread illness to other organs
NCI Cancer Center News
(Posted: 09/22/2014) - Scientists at The University of Texas MD Anderson Cancer Center have found that cancer cells traveling to other sites have different energy needs from their “stay-at-home” siblings which continue to proliferate at the original tumor site.

NCI’s Center for Global Health announces first major research grants to support portable technologies
NCI News Note
(Posted: 09/22/2014) - NCI’s Center for Global Health announced grants that will support the development and validation of low-cost, portable technologies. These technologies have the potential to improve early detection, diagnosis, and non-invasive or minimally invasive treatment of several cancer types that have a particularly high prevalence in a number of low- and middle-income countries.
View the article in Spanish

St. Jude researchers find that improved risk identification will aid fertility preservation in young male cancer patients
NCI Cancer Center News
(Posted: 09/17/2014) - St. Jude Children’s Research Hospital study has identified the cumulative dose of a widely used class of chemotherapy drugs that leaves young male cancer patients at risk for impaired sperm production as adults.

UCSD researchers find that cancer and the immune system are a double-edged sword
NCI Cancer Center News
(Posted: 09/16/2014) - During cancer development, tumor cells decorate their surfaces with sugar compounds called glycans that are different from those found on normal, healthy cells.

New knowledge of genes driving bladder cancer points to targeted treatments
NCI Cancer Center News
(Posted: 09/15/2014) - Dan Theodorescu, M.D., Ph.D., director of the University of Colorado Cancer Center, and colleagues from the National Cancer Institute show genes commonly mutated in bladder cancer, implying at least two.

U of Colorado researchers find a new drug could block gene driving cancer growth
NCI Cancer Center News
(Posted: 09/15/2014) - U of Colorado researchers find a new drug that could block a gene driving cancer activation, and could in principle be used to discover drugs aimed at other proteins driving human disease as well.

New genetic risk variants identified in multiethnic analysis of prostate cancer
NCI News Note
(Posted: 09/14/2014) - Researchers have newly identified 23 common genetic variants -- one-letter changes in DNA known as single-nucleotide polymorphisms or SNPs -- that are associated with risk of prostate cancer. These results come from an analysis of more than 10 million SNPs in data pooled from studies that included over 43,000 men with prostate cancer and nearly 44,000 men without the disease. Study participants were from Australia, Ghana, Japan, the United Kingdom, and the United States and were of diverse ancestry.

1 2 3 4 5 6 7 8 9 10 11  Next >